You can't make an omelet...

Whitehead biologist Rudolf Jaenisch spoke at Thomas Jefferson University in Philadelphia this Friday sharing with an audience of about 300 his thoughts on nuclear reprogramming (http://www.the-scientist.com/2005/4/25/13/1), and the promise of therapeutic cloning. Consistent with his former arguments and testimony before congress in 2001, he argued that human reproductive cloning is dangerous to the extent that it could be considered impossible. From this, he reasoned that critics worried about

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Whitehead biologist Rudolf Jaenisch spoke at Thomas Jefferson University in Philadelphia this Friday sharing with an audience of about 300 his thoughts on nuclear reprogramming (http://www.the-scientist.com/2005/4/25/13/1), and the promise of therapeutic cloning. Consistent with his former arguments and testimony before congress in 2001, he argued that human reproductive cloning is dangerous to the extent that it could be considered impossible. From this, he reasoned that critics worried about the destruction of viable human embryos during traditional routes to embryonic stem cells should have less to argue about with regards to stem cell lines created by somatic cell nuclear transfer. A fertilized embryo does have the potential to develop into a normal human baby whereas a cloned embryo does not. Nevertheless, Jaensich said he is hopeful that researchers can limit the use of egg cells in creating clonal totipotent stem cell lines. If only they can recapitulate the nuclear reprogramming that occurs during somatic cell nuclear transfer, the need for egg cells can be obviated, presumably skirting any reasonable bioethical arguments. But that may be a big presumption, and groups such as Jaenisch?s will never be able understand the complex reprogramming steps without doing the SCNT experiments in mammalian (including human) egg cells.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Brendan Maher

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo